Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Journal of Gastrointestinal Cancer|May 25, 2019
Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with CirrhosisWinston E Abara, P Spradling, Y Zhong, et al.MMWR. Morbidity and Mortality Weekly Report|March 3, 2022
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022Anne M Hause, James Baggs, Paige Marquez, et al.Population Health Management|August 14, 2023
The Predictive Value of International Classification of Disease Codes for Chronic Hepatitis C Virus Infection Surveillance: The Utility and Limitations of Electronic Health RecordsWinston E Abara, Anne C Moorman, Yuna Zhong, et al.MMWR. Morbidity and Mortality Weekly Report|July 14, 2022
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022Anne M Hause, James Baggs, Paige Marquez, et al.MMWR. Morbidity and Mortality Weekly Report|June 23, 2017
Screening for Syphilis and Other Sexually Transmitted Infections in Pregnant Women - Guam, 2014Susan Cha, Tasneem Malik, Winston E Abara, et al.MMWR. Morbidity and Mortality Weekly Report|August 5, 2021
COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021Anne M Hause, Julianne Gee, James Baggs, et al.MMWR. Morbidity and Mortality Weekly Report|July 28, 2022
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years - United States, March 29, 2022-July 10, 2022Anne M Hause, James Baggs, Paige Marquez, et al.JAMA Network Open|February 1, 2023
Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United StatesWinston E Abara, Julianne Gee, Paige Marquez, et al.The Journal of Infectious Diseases|March 28, 2019
Age-Related Differences in Past or Present Hepatitis C Virus Infection Among People Who Inject Drugs: National Human Immunodeficiency Virus Behavioral Surveillance, 8 US Cities, 2015Winston E Abara, Lindsay Trujillo, Dita Broz, et al.The Lancet. Infectious Diseases|April 15, 2022
Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational studyWinston E Abara, Kyle T Bernstein, Felicia M T Lewis, et al.Pageof 5